Skip to main content
Log in

Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives

  • LETTER TO THE EDITOR
  • Published:
Virchows Archiv Aims and scope Submit manuscript

The Original Article was published on 15 October 2022

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Metovic J, Cascardi E, Uccella S, Maragliano R, Querzoli G, Osella-Abate S, Pittaro A, La Rosa S, Bogina G, Cassoni P, Marchiò C, Sapino A, Castellano I, Papotti M (2022) Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome. Virchows Arch (in press). https://doi.org/10.1007/s00428-022-03426-0

    Article  Google Scholar 

  2. WHO Classification of Tumours Editorial Board (2019) WHO Classification of Tumours, 5th Edition. Breast tumours. International Agency for Research on Cancer, Lyon, France

  3. Kawasaki T, Mochizuki K, Yamauchi H, Inoue S, Kondo T, Oishi N, Nakazawa T, Yamane T, Koshimizu Y, Tsunoda H, Yagata H, Inoue M, Inoue A, Maruyama T, Fujii H, Katoh R (2012) Neuroendocrine cells associated with neuroendocrine carcinoma of the breast: nature and significance. J Clin Pathol 65(8):699–703. https://doi.org/10.1136/jclinpath-2012-200765

    Article  PubMed  Google Scholar 

  4. Kawasaki T, Kaira K (2021) Insulinoma-associated protein 1 (INSM1) expression in breast carcinomas with neuroendocrine morphologies: application and future prospective. Virchows Arch 479(1):191–194. https://doi.org/10.1007/s00428-020-02935-0

    Article  CAS  PubMed  Google Scholar 

  5. Metovic J, Castellano I, Marinelli E, Osella-Abate S, Sapino A, Cassoni P, Papotti M (2021) INSM1 expression in breast neoplasms with neuroedocrine features. Endocr Pathol 32(4):452–460. https://doi.org/10.1007/s12022-021-09682-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kawasaki T, Kaira K, Nakamura Y, Imai H, Barfod B (2021) Re: INSM1 is a novel prognostic neuroendocrine marker for luminal B breast cancer. Pathology 53(2):292–293. https://doi.org/10.1016/j.pathol.2020.12.001

Download references

Acknowledgements

The authors thank Mr. Satoshi Kanno, Mr. Tomio Honma, and Dr. Bierta Barfod for their technical assistance.

Funding

Tomonori Kawasaki is supported by Grants-in-Aid for Scientific Research (no. 21K06910 and no. 20K08131) from the Japanese Ministry of Education, Culture, Sports, Science and Technology and the National Hospital Organization (NHO) Grant (H29-NHO-01).

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: Tomonori Kawasaki, Tomoaki Tashima, Kyoichi Kaira; methodology: Tomonori Kawasaki, Hirokazu Nagai, Jiro Ichikawa, Kiyomi Taniyama; writing—original draft preparation: Tomonori Kawasaki, Tomoaki Tashima; writing—review and editing: Atsushi Enomoto, Tetsuo Kondo, Yasuhiro Nakamura, Kyoichi Kaira. All authors approved the final version of the manuscript.

Corresponding author

Correspondence to Tomonori Kawasaki.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawasaki, T., Tashima, T., Enomoto, A. et al. Neuroendocrine neoplasms of the breast: diagnostic confusion and future perspectives. Virchows Arch 482, 929–930 (2023). https://doi.org/10.1007/s00428-023-03513-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-023-03513-w

Navigation